Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $61.1M
Liabilities Breakdown FY2018
Total Liabilities: $114.0M
Asset Breakdown
Total Assets: $61.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.8M | 61.8% |
| Accounts Receivable | $4.7M | 7.7% |
| Inventory | $8.6M | 14.0% |
| Property, Plant & Equipment | $6.4M | 10.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.6M | 5.9% |
Liabilities Breakdown
Total Liabilities: $114.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $10.3M | 9.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $103.7M | 91.0% |